ID

19703

Beschrijving

Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00415285

Link

https://clinicaltrials.gov/show/NCT00415285

Trefwoorden

Versies (1)
  1. 23-01-17 23-01-17 -
Geüploaded op

23 januari 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Breast Neoplasms NCT00415285

Engels

Eligibility Breast Neoplasms NCT00415285

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed breast carcinoma.
Beschrijving

Breast Carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0678222
early stage breast cancer (stage 1, 2, 3).
Beschrijving

Early-Stage Breast Carcinoma TNM clinical staging

Datatype

boolean

Alias
UMLS CUI [1,1]
C2986665
UMLS CUI [1,2]
C3258246
no evidence of disease outside the breast or chest wall, except ipsilateral axillary lymph nodes.
Beschrijving

Disease outside Breast | Disease outside chest wall | Axillary lymph nodes Ipsilateral

Datatype

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205101
UMLS CUI [1,3]
C0006141
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205101
UMLS CUI [2,3]
C1279035
UMLS CUI [3,1]
C0729594
UMLS CUI [3,2]
C0441989
18 years of age or older.
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
Beschrijving

Eligibility Determination Final Health Professionals

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013893
UMLS CUI [1,2]
C3853528
UMLS CUI [1,3]
C1704312
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy, hormonal therapy, biologic therapy or radiation therapy for breast cancer.
Beschrijving

Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma | Biological treatment Breast Carcinoma | Therapeutic radiology procedure Breast Carcinoma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C0678222
UMLS CUI [3,1]
C1531518
UMLS CUI [3,2]
C0678222
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C0678222
major surgery within 28 days of study entry.
Beschrijving

major surgery

Datatype

boolean

Alias
UMLS CUI [1]
C0679637
evidence of cns metastases.
Beschrijving

CNS metastases Evidence of

Datatype

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0332120
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
Beschrijving

Eligibility Determination Final Health Professionals

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013893
UMLS CUI [1,2]
C3853528
UMLS CUI [1,3]
C1704312
Terug naar het begin van de pagina

Similar models

Eligibility Breast Neoplasms NCT00415285

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma
Item
histologically or cytologically confirmed breast carcinoma.
boolean
C0678222 (UMLS CUI [1])
Early-Stage Breast Carcinoma TNM clinical staging
Item
early stage breast cancer (stage 1, 2, 3).
boolean
C2986665 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Disease outside Breast | Disease outside chest wall | Axillary lymph nodes Ipsilateral
Item
no evidence of disease outside the breast or chest wall, except ipsilateral axillary lymph nodes.
boolean
C0012634 (UMLS CUI [1,1])
C0205101 (UMLS CUI [1,2])
C0006141 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C0205101 (UMLS CUI [2,2])
C1279035 (UMLS CUI [2,3])
C0729594 (UMLS CUI [3,1])
C0441989 (UMLS CUI [3,2])
Age
Item
18 years of age or older.
boolean
C0001779 (UMLS CUI [1])
Eligibility Determination Final Health Professionals
Item
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
boolean
C0013893 (UMLS CUI [1,1])
C3853528 (UMLS CUI [1,2])
C1704312 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Breast Carcinoma | Hormone Therapy Breast Carcinoma | Biological treatment Breast Carcinoma | Therapeutic radiology procedure Breast Carcinoma
Item
prior chemotherapy, hormonal therapy, biologic therapy or radiation therapy for breast cancer.
boolean
C0392920 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0279025 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C1531518 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0678222 (UMLS CUI [4,2])
major surgery
Item
major surgery within 28 days of study entry.
boolean
C0679637 (UMLS CUI [1])
CNS metastases Evidence of
Item
evidence of cns metastases.
boolean
C0686377 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Eligibility Determination Final Health Professionals
Item
final eligibility for a clinical trial is determined by the health professionals conducting the trial.
boolean
C0013893 (UMLS CUI [1,1])
C3853528 (UMLS CUI [1,2])
C1704312 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial